Documents & Downloads

AGI-134

Alpha-Gal Glycolipid

AGI-134 is a fully synthetic alpha-Gal glycolipid that targets CD8+ T cell-mediated immunity. It promotes the destruction of tumor cells and enhances phagocytic activity, making it a valuable tool for cancer research and immunotherapy studies. AGI-134 is instrumental in investigating immune responses against tumor-associated antigens and developing novel therapeutic strategies.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
CAS Number	1821461-84-0
Applications	Alpha-Gal Glycolipid
Formula	C₇₀H₁₂₆N₃O₂₆P
Molecular Weight	1456.73
SMILES	OC[C@@H](O[C@H]([C@@H]([C@H]1O)NC(C)=O)OCCCNC(CCCCC(NCCOP(OC[C@@H](COC(CCCCCCC/C=C\CCCCCCCC)=O)OC(CCCCCCC/C=C\CCCCCCCC)=O)(O)=O)=O)=O)[C@H]1O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O[C@H]3O[C@@H]([C@@H]([C@@H]([C@H]3O)O)O)CO)O

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.